News About: Pharm. Industry
KRPIA positively considers to prosecute unfair trade practices.
In line with forthcoming implementation of the new insurance drug price system, Actual Purchasing Price Reimbursement System, it is said that the foreign multinational drug corporation circle, KRPIA, positively studie...
Post administrative control on insurance drug prices to reinforce.
The MOHW plans to establish a strong administrative control system for insurance drug prices in association with the Korea Federation of Medical Insurance (KFMI) and the KPMA in line with the upcoming implementation o...
Financial safety in drug industry far improved last year.
According to the 1998 financial analysis reported by the Korea Industrial Development Bank, the pharmaceutical industry showed that the financial safety was good but profitability poor in 1998 compared to the previous...
Price order of insurance drugs necessary to establish.
In line with the government new pricing policy of "Actual Purchasing Price Reimbursement system" public opinions rose up that the drug industry could not escape from the total industrial collapse without establishing ...
KPMA asked for drug price slash to suspend
The Drug Trade Order Subcommittee of KPMA decided in the meeting on Sept. 20 to raise a recommendation to the MOHW about one or two month suspension of the overall drug price cut since many drug companies needed inter...
Drug price and medical reimbursement price adjusted simultaneously.
The 21st century forum of the KPMA concluded in their meeting on Sept. 13 and raised clear requests to the government that the issues of drug price reduction (30.7% on average) and the medical reimbursement price incr...
Green Cross acquired 7.3% shares of Sang-A
Green Cross purchased a massive portion of Sang-A's shares to become the 2nd majority shareholder. Sang-A pharmaceutical company was bankrupted and now under the court management control.
Green Cross bought 48,690 st...
Special notification to enact against unfair trade practice on insurance drugs.
The KPMA proposed to the Fair Trade Commission to legislate a special provision for blockading unfair drug trade practices such as an internal drug purchasing contract made between the hospital and the drug supplier s...
Pharmaceutical production shared 1.8% of GNP.
The contribution of drug production to the GNP showed remarkably declined last year. The total production value of drugs last year dropped by 2.1% from the previous year largely due to the IMF economic turmoils,...
Venture entrepreneur era predicted to come in drug industry.
Amid the pharmaceutical industry being emerged as one of the most attractive business in 21st century there appears a new sign for the R&D of drug industry in Korea. As many venture companies for an R&D of new drugs a...
